HLVXHilleVax, Inc.

Nasdaq hillevax.com


$ 12.80 $ 0.77 (6.41 %)    

Friday, 26-Apr-2024 15:59:26 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 12.79
$ 12.22
$ 12.65 x 100
$ 0.00 x 0
$ 12.22 - $ 13.11
$ 9.94 - $ 20.22
369,590
na
519.25M
$ 1.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-20-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-17-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-10-2022 06-30-2022 10-Q
8 06-08-2022 03-31-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-hillevax-maintains-28-price-target

HC Wainwright & Co. analyst Matthew Caufield reiterates HilleVax (NASDAQ:HLVX) with a Buy and maintains $28 price target.

 recap-hillevax-q4-earnings
Recap: HilleVax Q4 Earnings
03/20/2024 21:30:28

 hillevax-q4-2023-gaap-eps-078-beats-083-estimate

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.83) by 6...

 hc-wainwright--co-initiates-coverage-on-hillevax-with-buy-rating-announces-price-target-of-28

HC Wainwright & Co. analyst Matthew Caufield initiates coverage on HilleVax (NASDAQ:HLVX) with a Buy rating and announce...

 guggenheim-maintains-buy-on-hillevax-lowers-price-target-to-34

Guggenheim analyst Seamus Fernandez maintains HilleVax (NASDAQ:HLVX) with a Buy and lowers the price target from $38 to $34.

 stifel-maintains-buy-on-hillevax-lowers-price-target-to-30

Stifel analyst Stephen Willey maintains HilleVax (NASDAQ:HLVX) with a Buy and lowers the price target from $35 to $30.

 hillevax-q3-eps-081-beats-084-estimate

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.81) per share which beat the analyst consensus estimate of $(0.84) by 3...

 why-hillevax-shares-are-trading-lower

HilleVax Inc (NASDAQ: HLVX) shares are trading lower by 8.5% to $13.20 Wednesday morning after the company announced pricing of...

 hillevax-intends-to-offer-and-sell-100m-of-shares-of-its-common-stock-in-public-offering

 In addition, HilleVax expects to grant the underwriters a 30-day option to purchase up to an additional $15.0 million of share...

 jp-morgan-maintains-overweight-on-hillevax-lowers-price-target-to-22

JP Morgan analyst Eric Joseph maintains HilleVax (NASDAQ:HLVX) with a Overweight and lowers the price target from $23 to $22.

 hillevax-q1-earnings-insights
HilleVax: Q1 Earnings Insights
05/12/2023 21:10:10

 hillevax-q1-eps-071-beats-094-estimate

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.94) by 2...

 hillevax-q4-eps-056-beats-146-estimate

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(1.46) by 6...

 hillevax-announces-immunogenicity-results-for-run-in-cohort-of-nest-in1-phase-2b-clinical-trial-of-hil-214-norovirus-vaccine-candidate

HilleVax, Inc. (NASDAQ:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccin...

 best-buy-abercrombie--fitch-burlington-stores-and-some-other-big-stocks-moving-higher-on-tuesday

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Tuesday. Here are some big stocks recording gains in...

 hillevax-q3-eps-045-up-from-1003-yoy

HilleVax (NASDAQ:HLVX) reported quarterly losses of $(0.45) per share. This is a 95.51 percent increase over losses of $(10.03)...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION